LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 1 von insgesamt 1

Suchoptionen

Artikel ; Online: Effect of methylene blue on hemodynamic response in the early phase of septic shock: A case series.

Luis-Silva, Fabio / Menegueti, Mayra Gonçalves / Sato, Lucas / Peres, Leandro Moreira / Dos Reis Sepeda, Corina / Petroski-Moraes, Bruno C / Donadel, Mariana Dermínio / Gallo, Gabriela Bortoleto / Jordani, Maria Cecília / Mestriner, Fabiola / Becari, Christiane / Basile-Filho, Anibal / Evora, Paulo R B / Martins-Filho, Olindo Assis / Auxiliadora-Martins, Maria

Medicine

2023  Band 102, Heft 4, Seite(n) e32743

Abstract: Rationale: Methylene blue (MB) has been used to increase blood pressure in septic shock, acting on the activity of guanylate cyclase and nitric oxide synthase.: Patience concerns: The aim of this study is to demonstrate the benefit of MB in early ... ...

Abstract Rationale: Methylene blue (MB) has been used to increase blood pressure in septic shock, acting on the activity of guanylate cyclase and nitric oxide synthase.
Patience concerns: The aim of this study is to demonstrate the benefit of MB in early phase of septic shock.Diagnoses: We report 6 cases of patients with septic shock with up to 72 hours of evolution.
Interventions: We used MB after fluid replacement, use of norepinephrine and vasopressin. Patients received a loading dose of MB and maintenance for 48 hours.
Outcomes: All patients presented a reduction in the dose of vasopressors and lactate levels soon after the administration of the loading dose of MB, an effect that was maintained with the maintenance dose for 48 hours. Interleukin 6 and interleukin 8 were elevated at the beginning of the septic condition, with a progressive and marked reduction after the beginning of MB infusion, demonstrating a role of MB in reducing the inflammatory activity.
Lessons: This case series suggests that MB used early in the treatment of septic shock may be useful in reducing vasopressor dose and lactate levels. Further studies are still required to further validate these findings.
Mesh-Begriff(e) Humans ; Methylene Blue/pharmacology ; Methylene Blue/therapeutic use ; Shock, Septic ; Hemodynamics ; Blood Pressure/physiology ; Vasoconstrictor Agents/therapeutic use ; Norepinephrine/therapeutic use ; Lactates
Chemische Substanzen Methylene Blue (T42P99266K) ; Vasoconstrictor Agents ; Norepinephrine (X4W3ENH1CV) ; Lactates
Sprache Englisch
Erscheinungsdatum 2023-01-27
Erscheinungsland United States
Dokumenttyp Journal Article
ZDB-ID 80184-7
ISSN 1536-5964 ; 0025-7974
ISSN (online) 1536-5964
ISSN 0025-7974
DOI 10.1097/MD.0000000000032743
Signatur
Ua VI Zs.171: Hefte anzeigen Standort:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Kategorien

Zum Seitenanfang